A carregar...
The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer
Recurrent and/or metastatic squamous cell carcinoma of the head and neck (HNSCC) continues to be a source of significant morbidity and mortality worldwide. Agents that target the epidermal growth factor receptor (EGFR) have demonstrated beneficial effects in this setting. Cetuximab, a monoclonal ant...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2921255/ https://ncbi.nlm.nih.gov/pubmed/20714355 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|